Stay updated with breaking news from Tolerability Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Oncolytic virus CF33-hNIS (VAXINIA) alone or in combination with KEYTRUDA is a safe treatment option for advanced cancer patients.Encouraging VAXI...
The OASIS trial is a first-in-class clinical trial combining a CD19-expressing oncolytic virus, which flags solid tumours for attack by CD19-targe...
UZEDY significantly reduced the risk of relapse by up to 80% and prolonged the time to impending relapse by up to 5.0 times while having a similar safety profile to other formulations of... | May 20, 2023
ALPHARETTA, Ga., April 27, 2023 -- Clearside Biomedical, Inc. , a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space ,... | April 27, 2023
Imugene Ltd (ASX:IMU, OTC:IUGNF) welcomes the news that the first patients have been dosed in its Phase 1 MAST (metastatic advanced solid tumours) study...